Orthobiologics
Platelet rich plasma is a concentrate from blood that contains approximately three to five times more platelets than the normal concentration of platelets in human blood.
PRP promotes several types of cell activity, including inflammation, proliferation and remodeling, all of which are necessary in wound healing.
Blood is first drawn from a patient with a syringe using sterile technique and then centrifuged (spun) and separated out into three layers. The bottom layer is made up of red blood cells , the middle layer consists of platelets and white blood cells and the top layer is plasma.
The total volume of platelet rich plasma that is collected is approximately 5 milliliters or one teaspoon. Once it is prepared it is stable for up to eight hours, however once it is "activated" it must be used within ten minutes. The PRP is then delivered directly to the area of injury.
PRP is highly effective in muscle and tendon injuries in the fields of orthopedics and sports medicine.
It is used for injuries of tendons, muscles and ligaments. Common injuries that can be treated with PRP include
Based on the injury and location, several PRP treatments may be needed and may be as frequent as once a week as the full effect of PRP takes up to seven days. Since the platelet rich plasma promotes inflammation, there will be moderate discomfort after the treatment, yet this will subside with time and acetaminophen (Paracetamol) may be used for pain control.
Innovative cell therapy just for you!
Autologous Chondrocyte Implantation (ACI) is procedure that uses patients own cartilage tissue to treat defect area. Cartigrow cell therapy is a India's first ACI which is personalized, natural and curative treatment that regenerates the right type of cartilage. This enables the patient to perform all daily activities including sports. It helps in preventing total knee replacement in patients aged 18-65 years.
Indications
Benefits of CARTIGROW
Biopsy
Step I:
In a minor Arthroscopic procedure, a punch biopsy of healthy cartilage along with subchondral bone will be picked up and transported in specially designed kit to the cell processing center. Temperature during transit is maintained.
Culture
Step II:
Cartilage making chondrocytes cells will be isolated and multiplied to obtain a dose of 48 million containing chondrocytes. A number of quality analysis tests are performed on the cell dose. The process takes about 4 weeks
Implantation
Step III:
In an open procedure that requires about 30 minutes, the defect area is prepared and the personalized dose of chondrocytes will be implanted in to the defect area. The cell-gel mixture takes the shape of the defect area and settles in a firm jelly within 8-10 minutes.